Clinical and microbiological evaluation of miocamycin activity against group A beta-haemolytic streptococci in pediatric patients. Three years' incidence of erythromycin-resistant group A streptococci.
Borzani
M
M
Dept. of Pediatrics, School of Medicine, University of Milan, Italy.
Varotto
F
F
Garlaschi
L
L
Conio
F
F
Dell'Olio
M
M
Careddu
P
P
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D004917:Erythromycin / Q000627:therapeutic use*; D006801:Humans; D008826:Microbial Sensitivity Tests; D015644:Miocamycin / Q000627:therapeutic use*; D013290:Streptococcal Infections / Q000188:drug therapy*; D013297:Streptococcus pyogenes / Q000187:drug effects* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D015644:Miocamycin; D004917:Erythromycin